ERTUCO-S

Ertucos

ERTUCO-S

Sitagliptin

Atco Pharma International (Pvt) Ltd

Drug Identity

Active Ingredient
Sitagliptin
Drug Class
Blood Glucose Lowering Drugs, Excluding Insulin
0

How to Take It

Dosage information not available for this product.

Safety Alerts

Severe renal impairment, end-stage renal disease, or dialysis, Pancreatitis, Ketoacidosis

Important Warnings

Heart failure, renal impairment, hypotension, urosepsis and pyelonephritis, genital mycotic infection, increase LDL-C, severe arthralgia, pemphigoid, peripheral vascular disease, neuropathy, diabetic foot ulcer, high cholesterol level, gallstones

Side Effects

Hypoglycaemiahypovolaemiaincreased risk of infectionpolydipsiathirsturinary disordersvulvovaginal pruritus. Rare: Diabetic ketoacidosis (discontinue)Fourniers gangrene (discontinue). lower limb amputationsphimosis

Pregnancy & Lactation

Pregnancy
Contraindicated in pregnancy
Lactation
Contraindicated or not recommended

Price Intelligence

Rs 340
DVAGO observed price · as of 30 July 2026
No approved ceiling matched to this exact pack and strength.
Prices across sources
DVAGORs 340

Should you consider an alternative?

Other options containing Sitagliptin, and what they are not.You pay Rs 7 more than the cheapest equivalent

Identical active ingredient at the same strength. Cheapest per unit first.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.